News

Although influenza A H1N1 continues to dominate the current flu season in the US, H3N2 viruses are on the rise in some parts of the country.

Violence in the Democratic Republic of Congo has complicated public health efforts and overshadowed strides made in the response to the Ebola outbreak there.

T2 Biosystems, Inc. received FDA Breakthrough Device Designation for its T2Resistane Panel, a new device to aid in the fight against antimicrobial resistance.

Using genome sequencing, investigators have been able to identify clusters of individuals with HIV—with a particular focus on transgender women.

Powassan virus counts in the United States have been on the rise over the last decade, and now a new study sheds light on how ticks rapidly transmit the rare disease.

Women in the South look to family planning providers for more information about HIV PrEP, according a recent study in the journal Contraception.

The Contagion® editorial staff will be providing exclusive written and video coverage from CROI 2019.

State health care-associated infection reporting laws are critical for surveillance, but are they bogging down infection prevention programs?

With 6 ongoing outbreaks, cases reported across 10 states, and the FDA commissioner contemplating federal intervention, measles remains at the forefront of collective consciousness.

UK study in Addiction identifies benefits for controversial programs proposed as a solution for the ongoing opioid crisis.

Workers in a variety of industries—not just health care—face significant risk of infection at work. A new study finds a number of new risks are emerging, adding to the need for vigilance.

Spero Therapeutics announced that SPR720, an oral agent being developed for the treatment of lung infections caused by NTM, has received QIDP designation from the FDA.

Mycobacterium avium isolates were detected in household water in 81.1% of households sampled in a new study, suggesting a link to Mycobacterium avium complex lung disease.

#ICYMI, here are the highlights from Contagion®'s first-ever TweetChat on Treating Gram-Negative Infections in the Era of Resistance.

Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.

A new assay distinguishes between intact and defective HIV proviruses in infected cells, a study reports.

The length of mechanical friction applied to the needleless connector of a central venous catheter before insertion may make a difference in rate of disinfection.

A study conducted at the Salvador Zubirán National Institute of Health Sciences and Nutrition found that there were no cases of active tuberculosis detected in HSCT patients.

Investigators detected no relevant change in systemic concentrations of 9 probe drugs when rezafungin was dosed concomitantly.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Are we ignoring non-C diff infected rooms and promoting contamination?

The incidence of invasive meningococcal disease fell from 67% in the first quarter of the study period to 4% during the last quarter at a hospital in Spain.

The findings echo the guidelines published by IDSA/SHEA in 2018.

Concerns of at-risk patients forgoing condoms may be driving the reluctance of some clinicians to prescribe the preventive regimen.

A study reports that a respiratory virus infection diagnosis was not linked with a decrease in antibiotic exposure and use of respiratory viral panels did not affect clinical outcomes.

A new study finds that regular use of tenofovir gel helped reduce the risk of genital herpes acquisition in women in sub-Saharan Africa.

Following implementation of stewardship program-guided blood culture communication process, the time to optimal therapy was 9.2 hours shorter for patients at Saint Luke’s Hospital.

Ibuprofen succeeded in fighting S aureus in a laboratory setting, although it’s not clear whether the same effect would hold true in patients with systemic infections.

Rats and other pests pose significant problems for urban areas in the US.